CQDM funding opportunities rely on collaboration between public institutions with businesses in order to support the development of internationally competitive innovations with an industrial scope. Our programs provide essential support and financial leverage in order to:
- reduce risks and transform discoveries in the early stages of development into commercial products;
- develop technologies to increase productivity and manufacturing capability;
- strengthen R&D business capability through access to leading expertise; and
- encourage university researchers and students to get actively involved in collaborative research projects with an industrial scope.
These programs aim to catalyze the development cutting-edge innovations, to specifically meet market needs.
CQDM’s main funding opportunities
Overview of the main characteristics of CQDMs current funding opportunities
| Programs | SynergiQc | Quantum Leap | Partenar-IA |
|---|---|---|---|
| Eligible projects | Collaborative R&D relevant to the biopharmaceutical sector | R&D aimed at the maturation of innovations of interest for large pharmaceutical companies | Collaborative R&D using artificial intelligence relevant to the biopharmaceutical sector |
| Partners required | – 1 public research centre in Quebec – 1 business conducting R&D or production activities in Quebec | 1 public research centre or 1 Canadian business | – 2 businesses conducting R&D or production activities in Quebec, of which one is an SME – 1 public research centre in Quebec |
| Eligible expenses | Expenses incurred by the public research centre | Expenses incurred by the business and/or public research centre | Expenses incurred by the businesses and the public research centre |
| CQDM funding available | – Up to 40% of eligible expenses – Grant of up to $1.5 M | – Up to 33% of eligible expenses* – Financial support from CQDM of up to $400k* | – Up to 50% of eligible expenses – Grant of up to $350k per business |
| Predicted frequency of proposal submissions | Every 3 months | Every 3 months | Every 6 months |
| Contact person | Mathieu Paquette mpaquette@cqdm.org | Jesse Paterson jpaterson@cqdm.org | Mathieu Paquette mpaquette@cqdm.org |
New Funding Opportunity in RNA Therapies
Discover the CELLULE’s call for solutions, a collective comprised of Axelys, CQDM, Fonds de recherche du Québec, Génome Québec, and Médicament Québec. This new approach to supporting and funding innovations will accelerate the development of highly promising technologies with the potential to address critical industrial challenges that currently hinder the development and use of RNA therapies. The proposed technologies must specifically address the identified industrial challenges and meet the defined minimum performance criteria.
For any questions, please contact Alexandre Morizot, Director of Business Development, at amorizot@cqdm.org, and for more information, visit AReNA’s website: www.arenapole.ca
Other funding opportunities
Did you know? CQDM can help your business submit applications to investment funds in Quebec, particularly for requests to:
- The Innovation program, which aims to support businesses, first and foremost SMEs, in achieving their innovation projects in Quebec or in collaboration with international partners.
- The Impulsion PME program, which aims to help young, innovative businesses with a high-growth potential to gain access to investment capital in the start-up stage.
For any questions regarding funding opportunities offered by Quebec Investment funds, please contact Mathieu Paquette at mpaquette@cqdm.org
*Depending on the nature of projects considered, funding support from CQDM may exceed the limits established